NCT03353103

Brief Summary

This study will assess unstable plaque imaging features by using high resolution MR imaging and Sodium Fluoride F-18 PET. This is a comparative study between symptomatic and asymptomatic patient referred to carotid endateriectomy, with reference to pathologic analysis of plaque components

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Sep 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2017

Completed
8 months until next milestone

First Posted

Study publicly available on registry

November 27, 2017

Completed
9 months until next milestone

Study Start

First participant enrolled

September 3, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

January 13, 2020

Status Verified

January 1, 2020

Enrollment Period

1.7 years

First QC Date

April 14, 2017

Last Update Submit

January 9, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • carotid F18-NaF uptake

    do the symptomatic patients have a higher F18-NaF uptake compared to asymptomatic patients? at pre-operative examination

    baseline

Secondary Outcomes (3)

  • comparaison of F18-NaF PET and Carotid MRI

    baseline

  • F18-NaF PET uptake

    baseline

  • histology

    baseline

Study Arms (2)

symptomatic

ACTIVE COMPARATOR
Drug: Sodium fluoride F-18 PET imaging

asymptomatic

ACTIVE COMPARATOR
Drug: Sodium fluoride F-18 PET imaging

Interventions

prior to surgical endarterectomy each patient will undergo sodium fluoride F-18 PET imaging

asymptomaticsymptomatic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years old
  • Health care system affiliation
  • Referred to carotid endarterectomy
  • Symptomatic patients:
  • Carotid stenosis between 70 and 99% (NASCET criteria)
  • TIA or minor stroke attack (RANKIN ≤ 3)
  • Asymptomatic patients:
  • Carotid stenosis between 70 and 99% (NASCET criteria)
  • No symptoms
  • Patient who has been informed of the study and has given his/her informed consent

You may not qualify if:

  • Contra indication to MRI
  • Renal failure (clearance \< 30ml/mn)
  • Patient with active inflammatory disease
  • History of cancer
  • Pregnancy or lactation
  • Patient with carotid disease treated by fibrinolysis
  • Patient under guardianship, or unable to understand the purpose of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Caen University Hospital

Caen, France

RECRUITING

MeSH Terms

Conditions

Carotid Stenosis

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Lucie Cameliere, MD

CONTACT

Alain Manrique, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2017

First Posted

November 27, 2017

Study Start

September 3, 2018

Primary Completion

June 1, 2020

Study Completion

June 1, 2021

Last Updated

January 13, 2020

Record last verified: 2020-01

Locations